It has previously been shown that the expression of memory of maze-learning in mice is blocked by intracerebrally-injected puromycin one or more days after the training experience, and that bilateral adrenalectomy before training protects memory against this effect of puromycin. Purified cortrophin gel, injected subcutaneously up to 3 days before training, has now been found to give results like those obtained with adrenalectomy and, additionally, to provide a high degree of protection when injected up to 16 hr after training. Several possible explanations for these effects have been considered and found to be inadequate.
The expression of memory of maze-learning in mice is blocked for long periods of time by the intracerebral injection of puromycin one or more days after the training experience (1) . Bilateral adrenalectomy before, but not 1 day after, training protects memory against this action of puromycin (2) . We concluded that adrenalectomy before training modified factors necessary for the expression of memory, and that this alteration makes puromycin ineffective in blocking memory. We suggested that this effect might be related to the increase in ACTH that follows adrenalectomy (3) . In the present experiments, this possibility has been tested with a purified preparation of cortrophin gel, herein designated CG.
MATERIALS AND METHODS
The mice used were male and female Swiss-Webster, 5-10 months old, from our closed colony. They were trained in a Y-maze with a grid floor through which an electric shock, usually of 40 V, could be applied intermittently. For training, a mouse was placed in the stem of the Y. To avoid shock, it had to move into the correct arm within 5 sec. If a mouse entered the incorrect arm, intermittent shock was given until it moved to the correct arm. Training was conducted in one session of 10-20 min, to a criterion of 9 out of 10 correct responses. Total errors were the sum of incorrect choices and of latencies greater than 5 sec-i.e., all mistakes were added until, in 10 consecutive runs in the maze, the mouse had performed correctly in 9 of them. The same procedure was used in tests for the retention of memory of the training experience. These retention tests were given 1-2 weeks after learning. A final test of retention of relearning was given 1-2 weeks after the first retention test.
The injection technique has been fully described (4). Puromycin * 2HC1 (Nutritional Biochemicals Corp.) was neutralized to pH 6 with 1 equivalent of NaOH. All injections were bilateral, and each had a volume of 12 MA. All After finding that mice treated with CG before our training experience had normal retention of memory, we designed three sets of experiments. In the first set, mice were injected subcutaneously with CG at various times before training; 1 day after training they were injected intracerebrally with puromycin. CG injections were made 30-70 min (6 mice), 3-6 hr (11 mice), 1-3 days (16 mice), or 5 days (5 mice) before training. As controls for this and the following two sets of mice, the effectiveness of our puromycin solutions in blocking memory of normal mice was checked as needed. For this purpose, normal mice were trained and 1 day later were injected with puromycin; retention was then tested.
In addition, we have tested the possibility that the effective locus of the memory trace might develop beyond the hippocampal area to include large areas of the neocortex more rapidly than normally in the mice treated with CG. In & normal mouse, bitemporal injections of puromycin are effective for 3 days after training, whereas combined bitemporal, biventricular, and bifrontal injections are necessary to suppress memory at later times (4). Accordingly, five of the mice that had received CG 3 hr before training were treated 1 day after training with the six-combined injections of puromycin; the remaining mice of this series received bitemporal injections. A final set of controls was injected subcutaneously 3 hr before training with 15% gelatin (the vehicle used in our CG preparation) and 1 day later was treated with puromycin.
In the second set of experiments, mice were trained, subsequently treated with CG, and 1 day later treated with puromycin. Puromycin failed to block memory in mice injected immediately after training with CG (11 mice).
The interval between training and injection of CG was then 2519 The time between procedures is indicated over arrows. All mice treated with cortrophin gel (CG) received 12 U.S.P. units of ACTH activity. Groups la and e served as controls for groups lb, c and d; group 2, for groups in which treatment led to protection of memory against puromycin; group 3d, for group 3c; group 3e, for groups 3a, b, and c. Puro = puromycin -2HCl neutralized with NaOH. T = bitemporal and T + V + F = bitemporal, biventricular, and bifrontal injections. For the mice with retained memory, the means + SD for percentage savings of trials and errors were, respectively, 86 + 14 and 90 + 9; for those with impaired memory, 38 + 22 and 62 + 16; and for those with lost memory, 0 + 4 and 6 + 10.
increased first to 1-4 hr (9 mice); then, sequentially, to 8-16 hr (9 mice), 18-20 hr (5 mice), and 24 hr (11 mice). As a control for this set of mice, 15% gelatin was injected subcutaneously 30 min after training; 1 day later puromycin was injected.
In the third set of experiments, mice were trained, injected 1 day later with puromycin, and, after an additional 1-6 days, with CG.
RESULTS
Mice were inactive in their cages for about 1 hr after the injection of CG. Subsequent treatment with puromycin gave initially the same immediate symptoms as in normal miceabout 2 days of lethargy, reduced intake of food and water, and occasional convulsions. This short period of lethargy was followed by a longer one of hyperexcitability, so that some mice that received CG and puromycin required 2 weeks to recover normal cage behavior.
Treatment with CG caused a slight change in maze performance. For the 42 mice that received CG 30 min-3 days before initial training, the number of trials and total errors to criterion were, respectively, 13.2 + 0.7 (SE) and 13.8 + 0.8; for the 83 normal mice (those trained before any treatment was applied), 10.4 + 0.5 and 11.8 + 0.5. There is little difference between the two sets of means; the difference for errors is marginally significant (Student's t test, P < 0.05); that for trials, however, is significant (P < 0.01).
The effects on memory of the control and experimental procedures are given in Table 1 . Treatment with CG before training had no deleterious effect on retention of memory of the training experience (group la). Injection of puromycin into mice that had been treated with CG 0.5 hr-3 days before training was largely ineffective in suppressing memory; only 8% had complete loss of memory, whereas 74% retained memory to great extent (groups lb and d). There was no significant difference in the mean savings whether the mice were treated with the bitemporal or the six combined injections. By contrast, when mice were injected with CG 5 days before training, puromycin suppressed memory with regularity (group ic). The difference in savings of group lc and the controls in which gelatin was injected (group le) or in which puromycin was used without previous treatment (group 2) is not significant. When injected up to 16 hr after training, CG was as effective in protecting against the effects of puromycin (group 3a) as were the injections made up to 3 days before training (group lb). The protective action of CG was impaired when its injection was delayed until 18-20 hr after training (group 3b); there was a statistically significant loss in the mean savings of trials, though not in the means of errors. All protection was lost when treatment was delayed until 24 hr after training (group 3c). Injection of CG at this time into a control group, which subsequently received intracerebral injections of saline, had no deleterious effect on memory (group 3d).
Injections of CG a day or more after treatment with puromycin failed to protect memory (group 4).
Twelve of the mice used in these experiments had impaired memory on their final retention tests; the remainder showed retention of relearning at a high level.
DISCUSSION
Injections of CG, either before or after training, clearly protect memory against the amnestic effects of puromycin. As in the case of the protection that follows adrenalectomy before training (2), we have considered several explanations for this effect. We have reported that puromycin fails to suppress memory in mice that are overtrained, on the average, to 60 trials beyond criterion (1) . The mean number of trials and errors to criterion in mice treated with CG before training is so close to that of normal mice that this possibility appears to be ruled out. There is the further possibility that CG modifies the cellular interactions of puromycin, rather than processes concerned with memory. This possibility appears untenable in view of the drastic loss of memory observed in mice treated with CG 24 hr after training and with puromycin 1 day later, the same interval of time between the two injections that was used in many experiments in which puromycin failed to block memory. We must also reject the possibility that treatment with CG before training leads to an abnormally rapid development of an effective memory trace in wide areas of the neocortex (4); treatment 1 day after training with the six combined injections of puromycin was just as ineffective as the bitemporal injections. Finally, there is the possibility that motivational or other factors, not a part of the memory process itself, might account for the results (5), although we observed no difference to support this in the maze-behavior of mice that had been injected with CG before training and their controls. This explanation has been discarded in view of the finding that treatment with CG up to 16 hr after training protects memory against suppression by puromycin. The mode of action of CG in our experimental situation remains unknown. The ineffectiveness of treatment with CG 24 hr after training is consistent with the results found in mice adrenalectomized at this time (2) .
The protective effect of CG during a substantial period of time after training, and the prolonged protection (3 days) that follows its injection before training, call for comment.
The observations made after training provide further evidence that the consolidation of memory is time-dependent. This time-dependency has been demonstrated both by means of the disruptive effects of electroconvulsive shock (6) and by treating subjects, after training, with a number of drugs that improve memory (5) . The extended protection given by an injection of CG before training may be due to the survival of one or more pituitary peptides, or to the persistence of some secondary change that they produce.
It is premature to identify ACTH as the agent responsible for our results. Several pituitary peptides (ACTH, a-and fl-melanocyte stimulating hormone, vasopressin) have been found to delay extinction of a conditioned avoidance response (7) , indicating that they all may modify factors involved in memory. The preparation that we have used is not pure and contains an unknown number of peptides in concentrations (8) that are, except for ACTH, unknown; a more satisfactory understanding of our results depends upon the use of pure peptides.
